Edwards Lifesciences Corp Share-Based Compensation 2008-2026 | EW
What is share-based compensation?
Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.
What is Edwards Lifesciences Corp's current share-based compensation?
Edwards Lifesciences Corp (EW) annual share-based compensation for 2025 was $158.1M, a 2.59% decline from 2024. Edwards Lifesciences Corp share-based compensation for the quarter ending March 31, 2026 was $45.4M.
What was Edwards Lifesciences Corp's share-based compensation in 2024?
Edwards Lifesciences Corp annual share-based compensation for 2024 was $162.3M, a 16.43% increase from 2023.
What was Edwards Lifesciences Corp's share-based compensation in 2023?
Edwards Lifesciences Corp annual share-based compensation for 2023 was $139.4M, a 9.94% increase from 2022.
What is Edwards Lifesciences Corp's 5-year share-based compensation CAGR?
Edwards Lifesciences Corp share-based compensation grew at a compound annual growth rate (CAGR) of 11.29% from FY2020 to FY2025, going from $92.6M to $158.1M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $158.1M | -2.6% | 10-K |
| FY2024 | $162.3M | +16.4% | 10-K |
| FY2023 | $139.4M | +9.9% | 10-K |
| FY2022 | $126.8M | +16.0% | 10-K |
| FY2021 | $109.3M | +18.0% | 10-K |
| FY2020 | $92.6M | +13.9% | 10-K |
| FY2019 | $81.3M | +14.5% | 10-K |
| FY2018 | $71.0M | +15.3% | 10-K |
| FY2017 | $61.6M | +8.3% | 10-K |
| FY2016 | $56.9M | +14.0% | 10-K |
| FY2015 | $49.9M | +3.3% | 10-K |
| FY2014 | $48.3M | +1.9% | 10-K |
| FY2013 | $47.4M | +12.6% | 10-K |
| FY2012 | $42.1M | +20.3% | 10-K |
| FY2011 | $35.0M | +19.5% | 10-K |
| FY2010 | $29.3M | +3.5% | 10-K |
| FY2009 | $28.3M | -1.4% | 10-K |
| FY2008 | $28.7M | - | 10-K |